| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Amgen's product and service development landscape is showing strong promise, bolstered by significant advancements such as the innovative real-world evidence solutions from Landmark Science, which cater to the biopharma sector. The positive outlook is further supported by favorable results emerging from Phase III trials, paving the way for upcoming product launches. With a focus on personalized service and data-driven insights, Amgen is well-positioned for growth. However, challenges may arise in navigating regulatory hurdles and maintaining a competitive edge in an evolving market. |
| The price action of Amgen (AMGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.3 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for AMGN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.5, and the negative at -0.2 on 2025-05-04. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (2.9) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| AMGN | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-04 | 0%(0%) | 0 | 0% | 0.3 | 2.9 | -1 | |||||||
| 2025-05-03 | 0%(0%) | 0 | 0% | 0.4 | 3.4 | -1 | |||||||
| 2025-05-02 | 0%(0%) | 0 | 0% | 0.4 | 3.4 | -1 | |||||||
| 2025-05-01 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| 2025-04-30 | 0%(0%) | 0 | 0% | 0.1 | 1.4 | -1 | |||||||
| 2025-04-29 | 0%(0%) | 0 | 0% | -0.1 | 0.5 | -1 | |||||||
| 2025-04-28 | 0%(0%) | 0 | 0% | -0 | 0.9 | -1 | |||||||
| 2025-04-27 | 0%(0%) | 0 | 0% | -0.1 | 0.7 | -1 | |||||||
| 2025-04-26 | 0%(0%) | 0 | 0% | -0.1 | 0.7 | -1 | |||||||
| 2025-04-25 | 0%(0%) | 0 | 0% | -0.1 | 0.7 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-07-18 17:46:48 Amgen is viewed as undervalued with a high dividend yield, presenting a potential investment opportunity for buyers looking for growth and income. |
| 2025-07-18 17:46:48 The article discusses promising data from Phase III trials and upcoming product launches, indicating a positive outlook for Amgen's growth. |
| 2025-07-18 17:46:48 The presence of competitive therapies is a notable concern for Amgen, which could impact future performance and market position. |
| 2025-07-18 17:46:48 Despite positive earnings, the stock faced downward pressure due to prevailing market sentiment, suggesting volatility in investor attitudes. |
| 2025-07-18 17:46:48 The article highlights Amgen's strong Q1 performance with significant revenue growth and EPS improvement, indicating solid financial health. |